BRCA1 and breast cancer: Regarding the analysis of clinical data, Bojesen et al. showed that TERT rs10069690 is associated with a risk of estrogen receptor negative BC and BC in BRCA1 mutation carriers, which is consistent with another observation that showed that most incidents of BC arising from BRCA1 mutation carriers are estrogen receptor negative [40].